Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin’s lymphoma
Ziepert, M., Schmits, R., Trümper, L., Pfreundschuh, M., Loeffler, M.
Published in Annals of oncology (01.04.2008)
Published in Annals of oncology (01.04.2008)
Get full text
Journal Article
Human Neoplasms Elicit Multiple Specific Immune Responses in the Autologous Host
Sahin, Ugur, Tureci, Ozlem, Schmitt, Holger, Cochlovius, Bjorn, Johannes, Thomas, Schmits, Rudolf, Stenner, Frank, Luo, Guorong, Schobert, Ingrid, Pfreundschuh, Michael
Published in Proceedings of the National Academy of Sciences - PNAS (05.12.1995)
Published in Proceedings of the National Academy of Sciences - PNAS (05.12.1995)
Get full text
Journal Article
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)
Wunderlich, A., Kloess, M., Reiser, M., Rudolph, C., Truemper, L., Bittner, S., Schmalenberg, H., Schmits, R., Pfreundschuh, M., Loeffler, M.
Published in Annals of oncology (01.06.2003)
Published in Annals of oncology (01.06.2003)
Get full text
Journal Article
MSH2 deficient mice are viable and susceptible to lymphoid tumours
Reitmair, A.H, Schmits, R, Ewel, A, Bapat, B, Redston, M, Mitri, A, Waterhouse, P, Mittrücker, H.-W, Wakeham, A, Liu, B, Thomason, A, Griesser, H, Gallinger, S, Ballhausen, W.G, Fishel, R, Mak, T. W
Published in Nature genetics (01.09.1995)
Published in Nature genetics (01.09.1995)
Get full text
Journal Article
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens
Trümper, L., Zwick, C., Ziepert, M., Hohloch, K., Schmits, R., Mohren, M., Liersch, R., Bentz, M., Graeven, U., Wruck, U., Hoffmann, M., Metzner, B., Hasenclever, D., Loeffler, M., Pfreundschuh, M.
Published in Annals of oncology (01.03.2008)
Published in Annals of oncology (01.03.2008)
Get full text
Journal Article
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor
Schmits, R, Kündig, T M, Baker, D M, Shumaker, G, Simard, J J, Duncan, G, Wakeham, A, Shahinian, A, van der Heiden, A, Bachmann, M F, Ohashi, P S, Mak, T W, Hickstein, D D
Published in The Journal of experimental medicine (01.04.1996)
Published in The Journal of experimental medicine (01.04.1996)
Get full text
Journal Article
Advances in molecular biology diagnostic and treatment of B-cell malignancies
Get full text
Journal Article
Conference Proceeding
The cervical lymph node preparation: a novel approach to study lymphocyte homing by intravital microscopy
Schramm, R, Schäfers, H-J, Harder, Y, Schmits, R, Thorlacius, H, Menger, M D
Published in Inflammation research (01.04.2006)
Published in Inflammation research (01.04.2006)
Get full text
Journal Article
Lymphocyte function antigen 1 (LFA‐1) mediates early tumour necrosis factor α‐induced leucocyte adhesion in venules
Thorlacius, H., Vollmar, B., Guo, Y., Mak, T. W., Pfreundschuh, M. M., Menger, M. D., Schmits, R.
Published in British journal of haematology (01.08.2000)
Published in British journal of haematology (01.08.2000)
Get full text
Journal Article
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
Hiddemann, Wolfgang, Kneba, Michael, Dreyling, Martin, Schmitz, Norbert, Lengfelder, Eva, Schmits, Rudolf, Reiser, Marcel, Metzner, Bernd, Harder, Harriet, Hegewisch-Becker, Susanna, Fischer, Thomas, Kropff, Martin, Reis, Hans-Edgar, Freund, Mathias, Wörmann, Bernhard, Fuchs, Roland, Planker, Manfred, Schimke, Jörg, Eimermacher, Hartmut, Trümper, Lorenz, Aldaoud, Ali, Parwaresch, Reza, Unterhalt, Michael
Published in Blood (01.12.2005)
Published in Blood (01.12.2005)
Get full text
Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL
Pfreundschuh, Michael, Trümper, Lorenz, Kloess, Marita, Schmits, Rudolf, Feller, Alfred C., Rübe, Christian, Rudolph, Christian, Reiser, Marcel, Hossfeld, Dieter K., Eimermacher, Hartmut, Hasenclever, Dirk, Schmitz, Norbert, Loeffler, Markus
Published in Blood (01.08.2004)
Published in Blood (01.08.2004)
Get full text
Journal Article
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
Dreyling, Martin, Lenz, Georg, Hoster, Eva, Van Hoof, Achiel, Gisselbrecht, Christian, Schmits, Rudolf, Metzner, Bernd, Truemper, Lorenz, Reiser, Marcel, Steinhauer, Hjalmar, Boiron, Jean-Michel, Boogaerts, Marc A., Aldaoud, Ali, Silingardi, Vittorio, Kluin-Nelemans, Hanneke C., Hasford, Joerg, Parwaresch, Reza, Unterhalt, Michael, Hiddemann, Wolfgang
Published in Blood (01.04.2005)
Published in Blood (01.04.2005)
Get full text
Journal Article
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL
Pfreundschuh, Michael, Trümper, Lorenz, Kloess, Marita, Schmits, Rudolf, Feller, Alfred C., Rudolph, Christian, Reiser, Marcel, Hossfeld, Dieter K., Metzner, Bernd, Hasenclever, Dirk, Schmitz, Norbert, Glass, Bertram, Rübe, Christian, Loeffler, Markus
Published in Blood (01.08.2004)
Published in Blood (01.08.2004)
Get full text
Journal Article
Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model
Kubuschok, B, Cochlovius, C, Jung, W, Schmits, R, Trümper, L, Hartmann, F, Renner, C, Pfreundschuh, M
Published in Cancer gene therapy (01.09.2000)
Published in Cancer gene therapy (01.09.2000)
Get full text
Journal Article
Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma
Gause, A., Jung, W., Schmits, R., Tschiersch, A., Scholz, R., Pohl, C., Hasenclever, D., Diehl, V., Pfreundschuh, M.
Published in Annals of oncology (01.09.1992)
Published in Annals of oncology (01.09.1992)
Get full text
Journal Article
Conference Proceeding
Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered Within the German Multicenter Study (GIT NHL 02/96)
KOCH, Peter, PROBST, Andreas, BREITSPRECHER, Regine, SCHMITS, Rudolf, FREUND, Mathias, FIETKAU, Rainer, KETTERER, Peter, FREITAG, Eva-Maria, HINKELBEIN, Margit, HEMECKE, Achim, PARWARESCH, Reza, TIEMANN, Markus, BERDEL, Wolfgang E, WILLICH, Normann A, REINARTZ, Gabriele, BROCKMANN, Jens, LIERSCH, Rudiger, DEL VALLE, Francisco, CLASEN, Hermann, HIRT, Carsten
Published in Journal of clinical oncology (01.10.2005)
Published in Journal of clinical oncology (01.10.2005)
Get full text
Journal Article
Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis
Pfreundschuh, M, Pohl, C, Berenbeck, C, Schroeder, J, Jung, W, Schmits, R, Tschiersch, A, Diehl, V, Gause, A
Published in International journal of cancer (15.05.1990)
Published in International journal of cancer (15.05.1990)
Get more information
Journal Article
Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma
Gause, Angela, Roschansky, Volker, Tschiersch, Astrid, Smith, Kleri, Hasenclever, Dirk, Schmits, Rudolf, Diehl, Volker, Pfreundschuh, Michael
Published in Annals of oncology (01.02.1991)
Published in Annals of oncology (01.02.1991)
Get full text
Journal Article